Abhasnee Sobhonslidsuk

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

Philip J. Johnson, Shukui Qin, Joong‐Won Park et al. · Journal of Clinical Oncology · 2013 · 765 citations · Full text

Nutritional assessment in various stages of liver cirrhosis

Chulaporn Roongpisuthipong, Abhasnee Sobhonslidsuk, Kanokrat Nantiruj et al. · Nutrition · 2001 · 143 citations

Nutrition, Body Composition, Hepatology +11

Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial

Lai Wei, Seng Gee Lim, Qing Xie et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 120 citations

Hepatology, Hepatitis C, Viral Hepatitis +6

Factors influencing health-related quality of life in chronic liver disease

Abhasnee Sobhonslidsuk · World Journal of Gastroenterology · 2006 · 76 citations · Full text

A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury

Chote Luangchosiri, Ammarin Thakkinstian, Sermsiri Chitphuk et al. · BMC Complementary and Alternative Medicine · 2015 · 74 citations · Full text